Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 18, 2014
Granulocyte colony-stimulating factor therapy for stem cell mobilization following anterior wall myocardial infarction: the CAPITAL STEM MI randomized trialBenjamin Hibbert, Bradley Hayley, Robert S Beanlands, et al.International Journal of Cardiology|July 8, 2015
A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic windowNikita Malhotra, Joseph Abunassar, George A Wells, et al.Thrombosis and Haemostasis|October 21, 2016
A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS StudyAli Pourdjabbar, Benjamin Hibbert, Aun-Yeong Chong, et al.European Heart Journal. Acute Cardiovascular Care|August 12, 2021
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trialSimon Parlow, Pietro Di Santo, Rebecca Mathew, et al.The American Journal of Cardiology|November 19, 2021
Outcomes in Patients Stratified by PRECISE-DAPT Versus DAPT Scores After Percutaneous Coronary InterventionsRene Boudreau, Angel Y N Fu, Quinton S Barry, et al.Journal of the American College of Cardiology|September 29, 2012
Reduction in mortality as a result of direct transport from the field to a receiving center for primary percutaneous coronary interventionMichel R Le May, George A Wells, Derek Y So, et al.Coronary Artery Disease|October 16, 2020
Physician prediction of 1-year mortality in the cardiac catheterization laboratory: comparison to a validated risk scoreKiran Sarathy, Richard G Jung, Trevor Simard, et al.Clinical and Translational Science|December 2, 2020
Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular RiskTrevor Simard, Richard G Jung, Pietro Di Santo, et al.American Heart Journal|January 10, 2021
Acute kidney injury after radial or femoral artery access in ST-segment elevation myocardial infarction: AKI-SAFARIJeffrey A Marbach, George Wells, Pietro Di Santo, et al.BMJ Open|May 12, 2023
Rationale and Design of the Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion Trial (CAPITAL-RAPTOR)Pietro Di Santo, Omar Abdel-Razek, Richard Jung, et al.Pageof 6